Sylogist Stock Performance
SYZ Stock | CAD 10.05 0.05 0.50% |
The entity has a beta of -0.13, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Sylogist are expected to decrease at a much lower rate. During the bear market, Sylogist is likely to outperform the market. At this point, Sylogist has a negative expected return of -0.13%. Please make sure to validate Sylogist's total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if Sylogist performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Sylogist has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors. ...more
Forward Dividend Yield 0.004 | Payout Ratio 3.0769 | Last Split Factor 1:7 | Forward Dividend Rate 0.04 | Dividend Date 2024-12-11 |
1 | Sylogist Reports Strong Q3 2024 Results - TipRanks | 11/07/2024 |
Begin Period Cash Flow | 14.5 M |
Sylogist |
Sylogist Relative Risk vs. Return Landscape
If you would invest 1,105 in Sylogist on September 3, 2024 and sell it today you would lose (100.00) from holding Sylogist or give up 9.05% of portfolio value over 90 days. Sylogist is producing return of less than zero assuming 1.6854% volatility of returns over the 90 days investment horizon. Simply put, 15% of all stocks have less volatile historical return distribution than Sylogist, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
Sylogist Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sylogist's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Sylogist, and traders can use it to determine the average amount a Sylogist's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0796
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | SYZ |
Estimated Market Risk
1.69 actual daily | 15 85% of assets are more volatile |
Expected Return
-0.13 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Sylogist is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sylogist by adding Sylogist to a well-diversified portfolio.
Sylogist Fundamentals Growth
Sylogist Stock prices reflect investors' perceptions of the future prospects and financial health of Sylogist, and Sylogist fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sylogist Stock performance.
Return On Equity | -0.0335 | ||||
Return On Asset | 0.0258 | ||||
Profit Margin | (0.02) % | ||||
Operating Margin | 0.04 % | ||||
Current Valuation | 241.18 M | ||||
Shares Outstanding | 23.41 M | ||||
Price To Earning | 11.75 X | ||||
Price To Book | 6.69 X | ||||
Price To Sales | 3.54 X | ||||
Revenue | 65.51 M | ||||
Gross Profit | 33.9 M | ||||
EBITDA | 11.05 M | ||||
Net Income | 1.1 M | ||||
Cash Per Share | 0.52 X | ||||
Total Debt | 17.74 M | ||||
Debt To Equity | 0.66 % | ||||
Current Ratio | 0.46 X | ||||
Book Value Per Share | 1.50 X | ||||
Cash Flow From Operations | 9.93 M | ||||
Earnings Per Share | (0.05) X | ||||
Market Capitalization | 235.26 M | ||||
Total Asset | 96.58 M | ||||
Retained Earnings | (50.74 M) | ||||
Working Capital | (22.41 M) | ||||
About Sylogist Performance
By examining Sylogist's fundamental ratios, stakeholders can obtain critical insights into Sylogist's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Sylogist is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Last Reported | Projected for Next Year | ||
Days Of Inventory On Hand | 2.51 | 2.38 | |
Return On Tangible Assets | 0.04 | 0.04 | |
Return On Capital Employed | 0.02 | 0.02 | |
Return On Assets | 0.01 | 0.01 | |
Return On Equity | 0.03 | 0.03 |
Things to note about Sylogist performance evaluation
Checking the ongoing alerts about Sylogist for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sylogist help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Sylogist generated a negative expected return over the last 90 days | |
Sylogist has accumulated 17.74 M in total debt with debt to equity ratio (D/E) of 0.66, which is about average as compared to similar companies. Sylogist has a current ratio of 0.45, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Sylogist until it has trouble settling it off, either with new capital or with free cash flow. So, Sylogist's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Sylogist sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Sylogist to invest in growth at high rates of return. When we think about Sylogist's use of debt, we should always consider it together with cash and equity. | |
Latest headline from news.google.com: Sylogist Reports Strong Q3 2024 Results - TipRanks |
- Analyzing Sylogist's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sylogist's stock is overvalued or undervalued compared to its peers.
- Examining Sylogist's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sylogist's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sylogist's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sylogist's stock. These opinions can provide insight into Sylogist's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Sylogist Stock
Sylogist financial ratios help investors to determine whether Sylogist Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sylogist with respect to the benefits of owning Sylogist security.